TaqI polymorphism of VDR gene contributes to breast cancer risk
- 262 Downloads
Previous studies on the association of Vitamin D receptor (VDR) TaqI gene polymorphism with breast carcinogenesis have yielded inconsistent and inconclusive findings. The current meta-analysis was performed to provide a more precise assessment on the role of VDR TaqI polymorphism in breast cancer risk. 20 eligible case–control studies involving 9,055 cases and 10,516 controls were identified after a comprehensive literature search of the PubMed, Embase, Web of Science, and Wanfang databases. The pooled odds ratio (OR) with corresponding 95 % confidence interval (95 % CI) was calculated. Stratified analyses by ethnicity and study quality were conducted for further estimation. All statistical analyses were conducted by use of STATA (STATA Corporation, College Station, TX, Version 11.0). The overall ORs showed that the variant t allele and tt genotype were related to an increased risk of breast cancer (ORt vs. T = 1.05, 95 % CI 1.01–1.10, P OR = 0.025; ORtt vs. TT = 1.12, 95 % CI 1.03–1.23, P OR = 0.011; ORtt vs. Tt + TT = 1.10, 95 % CI 1.01–1.20, P OR = 0.023). Stratified analyses of studies in Caucasians and with high-quality further confirmed the results. However, no significant relationship was observed among Asians. This meta-analysis suggests that the VDR TaqI polymorphism confers risk effect on the breast cancer development, particularly in Caucasians.
KeywordsBreast cancer Vitamin D receptor TaqI Polymorphisms Meta-analysis
This work was supported by the Provincial Natural Science Foundation (S2012040006956).
Conflict of interests
- 1.Arriagada G, Paredes R, van Wijnen AJ, Lian JB, van Zundert B, Stein GS, et al. 1alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA. J Cell Physiol. 2010;222:336–46.PubMedCentralPubMedCrossRefGoogle Scholar
- 12.Vuolo L, Di Somma C, Faggiano A, Colao A. Vitamin D and cancer. Front Endocrinol (Lausanne). 2012;3:58.Google Scholar
- 16.Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013.Google Scholar
- 17.Tang LY, Chen LJ, Qi ML, Su Y, Su FX, Lin Y, et al. Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1. Gene. 2013.Google Scholar
- 22.Liu D, Zhang H, Zou T, Zhang Y, Yang Z, Ye T. Association between the genetic polymorphisms of Vitamin D receptor and sporadic breast cancer risk in Yunnan women of Han nationality. J Kunming Med Univer. 2011;32:91–4. Article in Chinese.Google Scholar
- 24.Huang Y, Lu H, Bai Y, Chen Y, Zeng Y, Pan Y. Relationship between genptypes and haplotypes of Vitamin D receptor gene and breast cancer risk. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;41:89–92. Article in Chinese.Google Scholar
- 33.Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarker Prev. 2002;11:1503–4.Google Scholar
- 56.Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, et al. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer. 2006;13:1109–20.PubMedCrossRefGoogle Scholar